Sandra Gurrola

Insider Reports History

Location
Carlsbad, CA
Signature
/s/ Sandra Gurrola
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Sandra Gurrola:

Company Role Class Num Shares Value Price $ Report Date Ownership
Ernexa Therapeutics Inc. Sr. VP of Finance Restricted Stock Units 0 $1,084 $2.48 21 Jun 2025 Direct
Ernexa Therapeutics Inc. Sr. VP of Finance Common Stock 110 $23 $0.2100 21 Jun 2025 Direct
Eterna Therapeutics Inc. Sr. VP of Finance Stock Option (Right to buy) 150,000 07 Feb 2025 Direct

Insider Reports Filed by Sandra Gurrola

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ERNA Ernexa Therapeutics Inc. 21 Jun 2025 2 $0 4 Sr. VP of Finance 07 Jul 2025, 20:00
ERNA Eterna Therapeutics Inc. 07 Feb 2025 1 $0 4 Sr. VP of Finance 10 Feb 2025, 19:00
ERNA Eterna Therapeutics Inc. 21 Jun 2024 3 -$349 4 Sr. VP of Finance 25 Jun 2024, 16:32
ERNA Eterna Therapeutics Inc. 26 Apr 2024 1 $0 4 Sr. VP of Finance 29 Apr 2024, 16:30
ERNA Eterna Therapeutics Inc. 21 Jun 2023 3 -$444 4 Vice President of Finance 23 Jun 2023, 20:30
ERNA Brooklyn ImmunoTherapeutics, Inc. 21 Jun 2022 3 -$1,709 4 Vice President of Finance 23 Jun 2022, 20:31
ERNA Brooklyn ImmunoTherapeutics, Inc. 11 Mar 2022 1 $0 4/A Vice President of Finance 17 Mar 2022, 21:00
ERNA Brooklyn ImmunoTherapeutics, Inc. 21 Jun 2021 1 $0 4 Vice President of Finance 22 Jun 2021, 18:01
ERNA Brooklyn ImmunoTherapeutics, Inc. 21 Jun 2021 0 $0 3 Vice President of Finance 22 Jun 2021, 18:00